Overview
IDXX market data
Price History
IDXX price chart
Valuation & Profitability
- P/E (TTM)
- 40.71 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $13.08 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.55 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $513.02 – $769.98 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $44.6K · P/B 33.65 · P/S 10.03.
Company news
Global Livestock Monitoring Market to Reach $10.3 Billion by 2030, Driven by Digital Agriculture TransformationGlobenewswire Inc · Jul 17, 2026, 1:15 PM
Veterinary Lab Automation Global Market Report 2023 Now Available, Covers Asia-Pacific, North America, Europe, and MoreGlobenewswire Inc · Jul 13, 2026, 12:45 PM
IDEXX Laboratories Expands Fecal Dx Antigen Testing Platform With Taeniid Tapeworm, Including Taenia And Echinococcus SpeciesBenzinga · May 26, 2026, 11:11 AM
Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic FrequencyBenzinga · May 5, 2026, 3:05 PM
8-K filing — IDEXX LABORATORIES INC /DE (IDXX)SEC EDGAR · May 5, 2026, 10:31 AM